The pahtway p172 has 42 genes in the original annotation. Currently, there are 33 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
|
Gene ID |
Symbol |
Synonyms |
Official Full Name |
Start Site |
End Site |
Location |
3265 | HRAS | C-BAS/HAS | C-H-RAS | C-HA-RAS1 | CTLO | H-RASIDX | HAMSV | HRAS1 | RASH1 | p21ras | Harvey rat sarcoma viral oncogene homolog | | | 11p15.5 |
7423 | VEGFB | VEGFL | VRF | vascular endothelial growth factor B | | | 11q13 |
595 | CCND1 | BCL1 | D11S287E | PRAD1 | U21B31 | cyclin D1 | | | 11q13 |
4312 | MMP1 | CLG | CLGN | matrix metallopeptidase 1 | | | 11q22.3 |
3845 | KRAS | C-K-RAS | CFC2 | K-RAS2A | K-RAS2B | K-RAS4A | K-RAS4B | KI-RAS | KRAS1 | KRAS2 | NS | NS3 | RALD | RASK2 | Kirsten rat sarcoma viral oncogene homolog | | | 12p12.1 |
1019 | CDK4 | CMM3 | PSK-J3 | cyclin-dependent kinase 4 | | | 12q14 |
4193 | MDM2 | ACTFS | HDMX | hdm2 | MDM2 proto-oncogene | | | 12q14.3-q15 |
5925 | RB1 | OSRC | PPP1R130 | RB | p105-Rb | pRb | pp110 | retinoblastoma 1 | | | 13q14.2 |
5228 | PGF | D12S1900 | PGFL | PLGF | PlGF-2 | SHGC-10760 | placental growth factor | | | 14q24.3 |
7057 | THBS1 | THBS | THBS-1 | TSP | TSP-1 | TSP1 | thrombospondin 1 | | | 15q15 |
5604 | MAP2K1 | CFC3 | MAPKK1 | MEK1 | MKK1 | PRKMK1 | mitogen-activated protein kinase kinase 1 | | | 15q22.1-q22.33 |
23604 | DAPK2 | DRP-1 | DRP1 | death-associated protein kinase 2 | | | 15q22.31 |
5595 | MAPK3 | ERK-1 | ERK1 | ERT2 | HS44KDAP | HUMKER1A | P44ERK1 | P44MAPK | PRKM3 | p44-ERK1 | p44-MAPK | mitogen-activated protein kinase 3 | | | 16p11.2 |
4313 | MMP2 | CLG4 | CLG4A | MMP-2 | MMP-II | MONA | TBE-1 | matrix metallopeptidase 2 | | | 16q12.2 |
7157 | TP53 | BCC7 | LFS1 | P53 | TRP53 | tumor protein p53 | | | 17p13.1 |
2064 | ERBB2 | CD340 | HER-2 | HER-2/neu | HER2 | MLN 19 | NEU | NGL | TKR1 | erb-b2 receptor tyrosine kinase 2 | | | 17q12 |
5605 | MAP2K2 | CFC4 | MAPKK2 | MEK2 | MKK2 | PRKMK2 | mitogen-activated protein kinase kinase 2 | | | 19p13.3 |
4893 | NRAS | ALPS4 | CMNS | N-ras | NCMS | NRAS1 | NS6 | neuroblastoma RAS viral (v-ras) oncogene homolog | | | 1p13.2 |
1870 | E2F2 | E2F-2 | E2F transcription factor 2 | | | 1p36 |
4318 | MMP9 | CLG4B | GELB | MANDP2 | MMP-9 | matrix metallopeptidase 9 | | | 20q13.12 |
5594 | MAPK1 | ERK | ERK-2 | ERK2 | ERT1 | MAPK2 | P42MAPK | PRKM1 | PRKM2 | p38 | p40 | p41 | p41mapk | p42-MAPK | mitogen-activated protein kinase 1 | | | 22q11.21 |
11186 | RASSF1 | 123F2 | NORE2A | RASSF1A | RDA32 | REH3P21 | Ras association domain family member 1 | | | 3p21.3 |
5894 | RAF1 | CMD1NN | CRAF | NS5 | Raf-1 | c-Raf | Raf-1 proto-oncogene, serine/threonine kinase | | | 3p25 |
2261 | FGFR3 | ACH | CD333 | CEK2 | HSFGFR3EX | JTK4 | fibroblast growth factor receptor 3 | | | 4p16.3 |
1950 | EGF | HOMG4 | URG | epidermal growth factor | | | 4q25 |
7422 | VEGFA | MVCD1 | VEGF | VPF | vascular endothelial growth factor A | | | 6p12 |
1026 | CDKN1A | CAP20 | CDKN1 | CIP1 | MDA-6 | P21 | SDI1 | WAF1 | p21CIP1 | cyclin-dependent kinase inhibitor 1A | | | 6p21.2 |
1871 | E2F3 | E2F-3 | E2F transcription factor 3 | | | 6p22 |
1956 | EGFR | ERBB | ERBB1 | HER1 | NISBD2 | PIG61 | mENA | epidermal growth factor receptor | | | 7p12 |
673 | BRAF | B-RAF1 | BRAF1 | NS7 | RAFB1 | B-Raf proto-oncogene, serine/threonine kinase | | | 7q34 |
4609 | MYC | MRTL | MYCC | bHLHe39 | c-Myc | v-myc avian myelocytomatosis viral oncogene homolog | | | 8q24.21 |
1029 | CDKN2A | ARF | CDK4I | CDKN2 | CMM2 | INK4 | INK4A | MLM | MTS-1 | MTS1 | P14 | P14ARF | P16 | P16-INK4A | P16INK4 | P16INK4A | P19 | P19ARF | TP16 | cyclin-dependent kinase inhibitor 2A | | | 9p21 |
1612 | DAPK1 | DAPK | death-associated protein kinase 1 | | | 9q21.33 |